In simvastatin-treated ccRCC cells, although RhoA was upregulated, it was mainly restrained in the cytosolic fraction and concomitantly reduced Rho-associated protein kinase activity. The gene discussed is RHOA; the disease is nonpapillary renal cell carcinoma.